Sponsor pipeline

Geron Corporation clinical trial pipeline

Get alerts when Geron Corporation's trials change

3 active trials 0 recruiting 2 Phase 3 2 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-27
Enrollment reduced: 36 → 30 participants
Enrollment closed, study ongoing
NCT05371964 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity… · Phase 1

Active trials by phase

Phase 1
1
Phase 2/3
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04576156 A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of… Myelofibrosis Active, Not Recruiting 2026-07-08
Phase 2/3
NCT02598661 Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic… Myelodysplastic Syndromes Active, Not Recruiting 2026-07-17
Phase 1
NCT05371964 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity… Myelofibrosis Active, Not Recruiting 2026-08-26

Disease areas by active trials

Myelofibrosis (2) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when Geron Corporation's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free